ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
5,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
6,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6,4,Prostatic pain,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
6,5,Prostatitis,Prostate and seminal vesicles infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
6,6,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
6,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
8,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,Y
9,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
13,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
15,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
15,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
18,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
18,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
21,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
21,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
22,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
23,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
24,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
24,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
24,3,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
24,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
24,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
24,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
25,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
25,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
25,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
25,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
26,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
27,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
28,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
28,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
29,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,2,Headache,Headaches NEC,Headaches,Nerv,N
29,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
30,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
31,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
33,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
34,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
35,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
36,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
37,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
37,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
37,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
38,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
40,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
41,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
41,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
41,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
42,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
43,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
44,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
45,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
45,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
45,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
45,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
45,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
45,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
46,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
47,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
47,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
47,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
49,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
50,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
51,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
52,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
52,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
52,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
54,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
54,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
54,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
54,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
58,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
59,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
59,3,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
60,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
61,1,Gallbladder cancer,Gallbladder neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
62,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
62,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
62,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
63,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
65,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
66,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
66,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
67,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
69,1,Adjustment disorder with mixed anxiety and depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
70,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
71,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
71,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
72,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
73,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
73,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
73,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
73,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,6,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
74,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
74,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
76,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
76,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
78,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
79,1,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
80,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
80,2,Headache,Headaches NEC,Headaches,Nerv,N
80,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
80,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
83,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
84,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
84,2,Migraine,Migraine headaches,Headaches,Nerv,N
84,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
85,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
85,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
85,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
86,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
86,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
87,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
87,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
87,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
88,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
90,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
90,2,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
92,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
93,1,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
93,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
94,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
95,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
96,1,T-cell chronic lymphocytic leukaemia,Leukaemias chronic T-cell,Leukaemias,Neopl,N
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
98,2,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
98,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
99,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
100,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
100,2,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
101,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
101,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
101,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
104,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
105,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
105,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
105,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
107,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
108,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
108,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
109,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
110,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
111,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
111,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
111,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
111,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
112,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
113,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,2,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
113,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
115,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
116,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
117,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
117,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
117,3,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
118,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
119,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
120,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
122,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
123,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
124,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
124,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
124,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
125,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
126,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
127,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
127,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
128,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
128,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
129,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
129,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
129,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
130,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
132,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
132,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
132,3,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
133,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
133,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
133,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
133,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
134,1,Headache,Headaches NEC,Headaches,Nerv,N
134,2,Infrequent bowel movements,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
134,3,Irregular sleep wake rhythm disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
135,1,Chronic hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
135,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
136,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
136,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
137,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,1,Alpha 1 foetoprotein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
138,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,3,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
139,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
139,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
139,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
139,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
141,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
141,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
141,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
143,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
143,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
144,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
145,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
145,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
146,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
146,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
146,3,Headache,Headaches NEC,Headaches,Nerv,N
146,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
146,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
146,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
147,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
149,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,1,Headache,Headaches NEC,Headaches,Nerv,N
150,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
152,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
152,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
152,3,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
152,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
152,5,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
152,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
154,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
154,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
154,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
155,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
156,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
156,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
156,6,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
156,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
158,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
159,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
161,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
161,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
162,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
163,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
164,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
165,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
165,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
167,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
168,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
169,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
169,2,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
170,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
171,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
172,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
173,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
174,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
174,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
175,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
175,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
175,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
175,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
176,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
178,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
181,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
182,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
183,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
188,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
188,2,Photoelectric conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
188,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
189,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
191,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
194,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
194,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
195,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
196,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
197,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
199,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
200,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
201,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
202,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
202,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
203,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
203,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
203,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
203,4,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
203,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
203,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
203,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
203,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
204,1,Headache,Headaches NEC,Headaches,Nerv,N
205,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
206,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
207,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
208,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
208,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
209,4,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
209,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
210,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
211,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
211,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
215,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
216,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
217,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
218,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,2,Headache,Headaches NEC,Headaches,Nerv,N
219,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
219,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
220,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
223,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
224,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
224,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
225,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
225,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
226,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
228,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
228,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
231,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
231,3,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
231,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
232,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
233,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
233,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
233,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
234,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
234,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
234,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
234,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
234,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
234,7,Hepatitis C RNA,Virus identification and serology,Microbiology and serology investigations,Inv,N
234,8,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
234,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
235,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
236,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
237,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
237,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
238,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
238,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
239,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
239,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
240,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
240,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
240,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
241,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
244,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
245,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
247,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
248,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
248,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
249,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
250,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,3,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
250,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
251,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
253,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
254,1,Hepatitis C RNA positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
254,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
257,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
257,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
